A new imaging approach being investigated by Memorial Sloan-Kettering researchers could provide better information about a tumor’s molecular activity, allowing for a more accurate diagnosis.

Researchers have found the first evidence that susceptibility to developing acute lymphoblastic leukemia during childhood may be heritable.

Information about the microbiome, the genes of all the microorganisms that naturally inhabit the human body, is leading to new approaches for treating infections in cancer patients.

Investigators have sequenced the genome of adenoid cystic carcinoma, a rare and deadly head and neck cancer. The work sets the stage for the sequencing of additional rare cancers at Memorial Sloan-Kettering.

An analysis of endometrial cancers reveals genetic information that should improve diagnosis and guide treatments for women with an aggressive form of the disease.

Scientists from Memorial Sloan-Kettering have collaborated on the discovery of a unique monoclonal antibody, called ESK1, that appears to be effective at targeting and destroying several types of cancer cells.

Researchers have shed light on how an important treatment for early-stage bladder cancer enters cancer cells to eradicate them.